Redwood Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-96,190
Closed -$14M 140
2017
Q3
$14M Sell
96,190
-28,270
-23% -$3.85M 1.6% 5
2017
Q2
$16.2M Sell
124,460
-19,746
-14% -$2.42M 1.63% 8
2017
Q1
$17.9M Sell
144,206
-38,919
-21% -$4.66M 1.78% 6
2016
Q4
$21.2M Sell
183,125
-52,610
-22% -$5.86M 1.91% 7
2016
Q3
$24.6M Buy
235,735
+89,134
+61% +$9.65M 1.88% 8
2016
Q2
$14.5M Buy
146,601
+5,168
+4% +$535K 1.33% 35
2016
Q1
$14.2M Buy
141,433
+939
+0.7% +$96.7K 1.41% 34
2015
Q4
$16.8M Buy
140,494
+20,650
+17% +$2.39M 1.8% 18
2015
Q3
$13M Buy
119,844
+6,608
+6% +$820K 1.73% 28
2015
Q2
$13.1M Buy
113,236
+20,519
+22% +$2.35M 1.62% 23
2015
Q1
$10.7M Sell
92,717
-17,349
-16% -$2.07M 1.71% 18
2014
Q4
$12.3M Sell
110,066
-126,360
-53% -$13.3M 1.86% 18
2014
Q3
$22.4M Sell
236,426
-18,266
-7% -$1.65M 2.99% 4
2014
Q2
$21.9M Buy
254,692
+15,208
+6% +$1.16M 2.74% 5
2014
Q1
$16.7M Buy
239,484
+36,244
+18% +$2.87M 2.41% 9
2013
Q4
$17.2M Sell
203,240
-26,986
-12% -$2.14M 2.57% 6
2013
Q3
$17.7M Sell
230,226
-856
-0.4% -$60K 2.51% 3
2013
Q2
$13.5M Buy
+231,082
New +$13.9M 2.09% 12

Other funds holding CELG

Redwood Investments's CELG Position: Q4 2017 in Review

Redwood Investments sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 96,190 shares — an estimated $14M sold.

Redwood Investments first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $24.6M in Q3 2016. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Redwood Investments reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Redwood Investments sold 96,190 Celgene Corp shares in Q4 2017, an estimated $14M.
  • Redwood Investments first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
  • Redwood Investments's Celgene Corp position peaked at $24.6M in Q3 2016.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Redwood Investments's 13F filing for Q4 2017, filed 14 Feb 2018.